[go: up one dir, main page]

PL2768985T3 - Biomarkery będące krążącymi kwasami nukleinowymi związane z rakiem jelita grubego - Google Patents

Biomarkery będące krążącymi kwasami nukleinowymi związane z rakiem jelita grubego

Info

Publication number
PL2768985T3
PL2768985T3 PL12846333T PL12846333T PL2768985T3 PL 2768985 T3 PL2768985 T3 PL 2768985T3 PL 12846333 T PL12846333 T PL 12846333T PL 12846333 T PL12846333 T PL 12846333T PL 2768985 T3 PL2768985 T3 PL 2768985T3
Authority
PL
Poland
Prior art keywords
nucleic acid
colorectal cancer
cancer associated
circulating nucleic
acid biomarkers
Prior art date
Application number
PL12846333T
Other languages
English (en)
Inventor
Ekkehard Schutz
Julia Beck
Howard Urnovitz
Original Assignee
Chronix Biomedical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chronix Biomedical filed Critical Chronix Biomedical
Publication of PL2768985T3 publication Critical patent/PL2768985T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing
    • C12Q1/6874Methods for sequencing involving nucleic acid arrays, e.g. sequencing by hybridisation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PL12846333T 2011-10-21 2012-10-19 Biomarkery będące krążącymi kwasami nukleinowymi związane z rakiem jelita grubego PL2768985T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161550098P 2011-10-21 2011-10-21
EP12846333.8A EP2768985B1 (en) 2011-10-21 2012-10-19 Colorectal cancer associated circulating nucleic acid biomarkers
PCT/US2012/061044 WO2013066641A1 (en) 2011-10-21 2012-10-19 Colorectal cancer associated circulating nucleic acid biomarkers

Publications (1)

Publication Number Publication Date
PL2768985T3 true PL2768985T3 (pl) 2019-10-31

Family

ID=48192610

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12846333T PL2768985T3 (pl) 2011-10-21 2012-10-19 Biomarkery będące krążącymi kwasami nukleinowymi związane z rakiem jelita grubego

Country Status (6)

Country Link
US (3) US20140303008A1 (pl)
EP (1) EP2768985B1 (pl)
CA (1) CA2852098C (pl)
ES (1) ES2729554T3 (pl)
PL (1) PL2768985T3 (pl)
WO (1) WO2013066641A1 (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3216874A1 (en) 2008-09-05 2017-09-13 TOMA Biosciences, Inc. Methods for stratifying and annotating cancer drug treatment options
KR20130113447A (ko) 2010-09-24 2013-10-15 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 고정된 프라이머들을 이용하여 표적 dna의 직접적인 캡쳐, 증폭 및 서열화
US9260753B2 (en) 2011-03-24 2016-02-16 President And Fellows Of Harvard College Single cell nucleic acid detection and analysis
US20160040229A1 (en) 2013-08-16 2016-02-11 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
KR102393608B1 (ko) 2012-09-04 2022-05-03 가던트 헬쓰, 인크. 희귀 돌연변이 및 카피수 변이를 검출하기 위한 시스템 및 방법
US11913065B2 (en) 2012-09-04 2024-02-27 Guardent Health, Inc. Systems and methods to detect rare mutations and copy number variation
US10876152B2 (en) 2012-09-04 2020-12-29 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
WO2015017520A1 (en) * 2013-07-30 2015-02-05 Tetralogic Pharmaceuticals Corp. Method of treatment
EP3378952B1 (en) 2013-12-28 2020-02-05 Guardant Health, Inc. Methods and systems for detecting genetic variants
US11062789B2 (en) 2014-07-18 2021-07-13 The Chinese University Of Hong Kong Methylation pattern analysis of tissues in a DNA mixture
JP2019507585A (ja) 2015-12-17 2019-03-22 ガーダント ヘルス, インコーポレイテッド 無細胞dnaの分析による腫瘍遺伝子コピー数を決定するための方法
US10781490B2 (en) 2016-05-30 2020-09-22 The Chinese University Of Hong Kong Detecting hematological disorders using cell-free DNA in blood
US9850523B1 (en) 2016-09-30 2017-12-26 Guardant Health, Inc. Methods for multi-resolution analysis of cell-free nucleic acids
EP3792922A1 (en) 2016-09-30 2021-03-17 Guardant Health, Inc. Methods for multi-resolution analysis of cell-free nucleic acids
SG11201903509QA (en) 2016-10-24 2019-05-30 Univ Hong Kong Chinese Methods and systems for tumor detection
WO2018099418A1 (en) 2016-11-30 2018-06-07 The Chinese University Of Hong Kong Analysis of cell-free dna in urine and other samples
MY197535A (en) 2017-01-25 2023-06-21 Univ Hong Kong Chinese Diagnostic applications using nucleic acid fragments
DK3658684T3 (da) 2017-07-26 2023-10-09 Univ Hong Kong Chinese Forbedring af cancerscreening ved hjælp af cellefrie, virale nukleinsyrer
US12027237B2 (en) 2018-03-13 2024-07-02 Grail, Llc Anomalous fragment detection and classification
US12234514B2 (en) 2018-12-21 2025-02-25 Grail, Inc. Source of origin deconvolution based on methylation fragments in cell-free DNA samples
EP3918089B1 (en) 2019-01-31 2025-01-15 Guardant Health, Inc. Method for isolating and sequencing cell-free dna
CN113728116A (zh) * 2019-02-22 2021-11-30 安可济控股有限公司 用于早期癌症检测的方法和组合物

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340843C (en) 1987-07-31 1999-12-07 J. Lawrence Burg Selective amplification of target polynucleotide sequences
CA1340807C (en) 1988-02-24 1999-11-02 Lawrence T. Malek Nucleic acid amplification process
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
CA2020958C (en) 1989-07-11 2005-01-11 Daniel L. Kacian Nucleic acid sequence amplification methods
US5955589A (en) 1991-12-24 1999-09-21 Isis Pharmaceuticals Inc. Gapped 2' modified oligonucleotides
JP2985446B2 (ja) 1990-10-31 1999-11-29 東ソー株式会社 核酸の検出及び測定方法
IE913930A1 (en) 1990-11-13 1992-06-17 Siska Diagnostics Nucleic acid amplification by two-enzyme, self-sustained¹sequence replication
YU187991A (sh) 1990-12-11 1994-09-09 Hoechst Aktiengesellschaft 3-(2)-amino-ali tiol-modifikovani, s fluorescentnom bojom vezani nukleozidi, nukleotidi i oligonukleotidi, postupak za njihovo dobijanje i njihova upotreba
US5455166A (en) 1991-01-31 1995-10-03 Becton, Dickinson And Company Strand displacement amplification
US5994056A (en) 1991-05-02 1999-11-30 Roche Molecular Systems, Inc. Homogeneous methods for nucleic acid amplification and detection
US5652099A (en) 1992-02-12 1997-07-29 Conrad; Michael J. Probes comprising fluorescent nucleosides and uses thereof
US5837832A (en) 1993-06-25 1998-11-17 Affymetrix, Inc. Arrays of nucleic acid probes on biological chips
AU8126694A (en) 1993-10-26 1995-05-22 Affymax Technologies N.V. Arrays of nucleic acid probes on biological chips
US5446137B1 (en) 1993-12-09 1998-10-06 Behringwerke Ag Oligonucleotides containing 4'-substituted nucleotides
DE4415370A1 (de) 1994-05-02 1995-11-09 Hoechst Ag Modifizierte Oligonukleotide, deren Herstellung sowie deren Verwendung
US5807522A (en) 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
DE4438918A1 (de) 1994-11-04 1996-05-09 Hoechst Ag Modifizierte Oligonukleotide, deren Herstellung sowie deren Verwendung
EP0866071B1 (en) 1997-03-20 2004-10-20 F. Hoffmann-La Roche Ag Modified primers
CA2321070C (en) 1998-02-23 2010-04-06 Wisconsin Alumni Research Foundation Method and apparatus for synthesis of arrays of dna probes
AU4333799A (en) 1998-06-04 1999-12-20 Board Of Regents, The University Of Texas System Digital optical chemistry micromirror imager
US6315958B1 (en) 1999-11-10 2001-11-13 Wisconsin Alumni Research Foundation Flow cell for synthesis of arrays of DNA probes and the like
US20030165895A1 (en) * 2001-06-12 2003-09-04 Bogdan Czerniak Methods of detecting, diagnosing and treating cancer and identifying neoplastic progression
US20040126757A1 (en) 2002-01-31 2004-07-01 Francesco Cerrina Method and apparatus for synthesis of arrays of DNA probes
US7422851B2 (en) 2002-01-31 2008-09-09 Nimblegen Systems, Inc. Correction for illumination non-uniformity during the synthesis of arrays of oligomers
US7157229B2 (en) 2002-01-31 2007-01-02 Nimblegen Systems, Inc. Prepatterned substrate for optical synthesis of DNA probes
US7083975B2 (en) 2002-02-01 2006-08-01 Roland Green Microarray synthesis instrument and method
US7498176B2 (en) 2002-09-27 2009-03-03 Roche Nimblegen, Inc. Microarray with hydrophobic barriers
US20040110212A1 (en) 2002-09-30 2004-06-10 Mccormick Mark Microarrays with visual alignment marks
DE10348407A1 (de) 2003-10-17 2005-05-19 Widschwendter, Martin, Prof. Prognostische und diagnostische Marker für Zell-proliferative Erkrankungen von Brustgeweben
JP2008524986A (ja) * 2004-12-10 2008-07-17 バイエル・ヘルスケア・アクチェンゲゼルシャフト タキサンに基づく薬物療法に対する悪性腫瘍の応答予測に有用な遺伝子変化
JP2008536480A (ja) * 2005-02-17 2008-09-11 ダナ−ファーバー キャンサー インスティテュート,インコーポレイテッド 癌の同定、評価、予防、および治療用組成物、キット、および方法、ならびに癌の治療法
US20090280479A1 (en) 2005-05-27 2009-11-12 John Wayne Cancer Institute Use of free circulating dna for diagnosis, prognosis, and treatment of cancer funding
TW200730825A (en) * 2005-10-21 2007-08-16 Genenews Inc Method and apparatus for correlating levels of biomarker products with disease
AU2007334393A1 (en) 2006-12-14 2008-06-26 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
US12180549B2 (en) 2007-07-23 2024-12-31 The Chinese University Of Hong Kong Diagnosing fetal chromosomal aneuploidy using genomic sequencing
WO2009051842A2 (en) 2007-10-18 2009-04-23 The Johns Hopkins University Detection of cancer by measuring genomic copy number and strand length in cell-free dna
US20100035252A1 (en) 2008-08-08 2010-02-11 Ion Torrent Systems Incorporated Methods for sequencing individual nucleic acids under tension
US8835110B2 (en) 2008-11-04 2014-09-16 The Johns Hopkins University DNA integrity assay (DIA) for cancer diagnostics, using confocal fluorescence spectroscopy
EP3181705A1 (en) * 2008-11-12 2017-06-21 Caris Life Sciences Switzerland Holdings GmbH Methods and systems of using exosomes for determining phenotypes
US20100136560A1 (en) 2008-12-02 2010-06-03 The Johns Hopkins University Integrated Analyses of Breast and Colorectal Cancers
US20120220478A1 (en) 2009-07-20 2012-08-30 Bar Harbor Biotechnology, Inc. Methods for assessing disease risk
CA2795776A1 (en) * 2010-04-06 2011-10-13 Caris Life Sciences Luxembourg Holdings, S.A.R.L. Circulating biomarkers for disease
PL2558854T3 (pl) * 2010-04-16 2019-04-30 Chronix Biomedical Biomarkery będące krążącymi kwasami nukleinowymi związanymi z rakiem piersi

Also Published As

Publication number Publication date
EP2768985A1 (en) 2014-08-27
US20250340937A1 (en) 2025-11-06
US12359252B2 (en) 2025-07-15
US20140303008A1 (en) 2014-10-09
EP2768985A4 (en) 2015-07-01
US20190136314A1 (en) 2019-05-09
EP2768985B1 (en) 2019-03-20
WO2013066641A1 (en) 2013-05-10
ES2729554T3 (es) 2019-11-04
CA2852098C (en) 2023-05-02
CA2852098A1 (en) 2013-05-10

Similar Documents

Publication Publication Date Title
PL2768985T3 (pl) Biomarkery będące krążącymi kwasami nukleinowymi związane z rakiem jelita grubego
PL2558854T3 (pl) Biomarkery będące krążącymi kwasami nukleinowymi związanymi z rakiem piersi
PL2576837T3 (pl) Krążeniowe biomarkery typu kwasu nukleinowego związane z rakiem prostaty
EP2718721A4 (en) CIRCULATING BIOMARKERS FOR CANCER
EP2678448A4 (en) CIRCULATING BIOMARKERS
IL222232A0 (en) Circulating biomarkers for disease
EP2606353A4 (en) CIRCULATING BIOMARKERS FOR DISEASE
IL229319A0 (en) Lung cancer biomarkers
EP2825674A4 (en) BIOMARKER FOR THYROID CANCER
ZA201205891B (en) Dna polymerases
EP2739754A4 (en) MICRO-RNA biomarkers
PL3296319T3 (pl) Sposoby leczenia nowotworu jelita grubego
GB201204407D0 (en) Nucleic acid molecule
PT2876447T (pt) Método para deteção de cancro
EP2994545A4 (en) Dna methylation biomarkers for bladder cancer
ZA201408120B (en) Diagnostic gene marker panel for colorectal cancer
EP3090264A4 (en) Circulating tumor cell diagnostics for lung cancer
IL235459A0 (en) Ways to treat non-small cell lung cancer
EP2890783A4 (en) WITNESSES FOR NUCLEIC ACID ASSAYS
PL2876446T3 (pl) Sposób wykrywania nowotworu
EP2833149A4 (en) METHOD FOR DETECTING THE MALIGNANCE DEGREE OF A CIRCULATING TUMOR CELL UNIT AND KIT THEREFOR
ZA201206793B (en) Nucleic acid complexes
IL227419A0 (en) Symptomatic signature for colon cancer recurrence
GB2510784B (en) Data sharing using difference-on-write
GB2510539B (en) Biomarkers of cancer